Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021 7 1
Theaflavin 3,3'-digallate Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021 3 0
Tilorone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 3 0
Amentoflavone Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 4 0
Vortioxetine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/05/2021 2 0
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021 12 1
Agathisflavone Potential treatment - theoretical effect Natural product Antiviral Dec/10/2020 2 0